Sharps Compliance — Barrington Research Growth Conference 2011
23 slides from Sharps Compliance's conference presentation, Sep 7, 2011

Slide 1: Sharps Compliance Corp.
800.772.5657 / www.sharpsinc.com Sharps Compliance Corp. NASDAQ: SMED Barrington Research Growth Conference September 7, 2011 Diana P. Diaz Vice President and Chief Financial Officer David Tusa Chief Executive Officer and President

Slide 2: Safe Harbor Statement
800.772.5657 / www.sharpsinc.com Safe Harbor Statement These slides contain (and the accompanying oral discussion will contain) “ forward-looking statements ” within the meaning of the Private Securities Litigation Reform Act of 1995. The words “ believe ” , “ estimate ” , “ anticipate ” , “ project

Slide 3: Sharps Compliance
800.772.5657 / www.sharpsinc.com Sharps Compliance NASDAQ: SMED Market capitalization $61.35 million Recent price $4.09 52-week range $6.19 - $2.66 Avg. daily trading volume (3 mos.) 70,205 Market data as of August 30, 2011, ownership as of most recent filing Fiscal Year-End June 30 th Total shares

Slide 4: Sharps Recovery System Sharps Disposal Legislation for Self-Injectors
Sharps Recovery System™ Sharps Disposal Legislation for Self-Injectors ♦ Proposed or enacted legislation covers 43% of the U.S. population (18 states plus D.C.) Medical Professional Sharps Recovery System™ Sharps Recovery System™ $1 Billion Unregulated Market Opportunity ♦ Estimated 3 billion used s

Slide 5: TakeAway Environmental Return System Unused Medication Disposal Legislation
TakeAway Environmental Return System™ Unused Medication Disposal Legislation ♦ Proposed or enacted legislation covers 65% of the U.S. population (29 states plus D.C.) $1 Billion Market Opportunity ♦ 40% of dispensed medications from 4 billion prescriptions go unused annually ♦ Estimated 200 million

Slide 6: Vertically Integrated Solutions Provider
800.772.5657 / www.sharpsinc.com Vertically Integrated Solutions Provider SharpsTracer™ MedTracer™ Fully integrated including manufacturing, assembly, distribution, treatment, online tracking and customer reporting Two manufacturing, assembly, and distribution facilities: Texas and Georgia Regulator

Slide 7: Key Markets: Retail Pharmacies
Key Markets: Retail Pharmacies ü Unused medication envelope solution now has a shelf presence in some of the nation’s largest drug chains ü Drives foot traffic and customer interaction ü Introduced to retail market in September 2010 ü Total Market Opportunity: $40 million (TakeAway envelope only) Sh

Slide 8: Key Markets: Pharmaceutical Manufacturers
Key Markets: Pharmaceutical Manufacturers Recent wins for Sharps Pharmaceutical manufacturers of self-injectible medications are focused on: ü Product differentiation ü Improved interaction with patients ü Creating a touch point for patient follow-up and improved therapy outcomes Sharps awarded pati

Slide 9: Key Markets: Professional
800.772.5657 / www.sharpsinc.com Key Markets: Professional Launched inside sales initiative in January 2010 Driving Awareness Recurring Revenue Opportunities Educating the Market Launched new website and corresponding promotional activity in mid July 2011 Sharps Recovery System™ ü Support the proper

Slide 10: Key Markets: Core Government - Department of Veterans Affairs Pilot Program
800.772.5657 / www.sharpsinc.com Key Markets: Core Government U.S. Department of Veterans Affairs Innovative Pilot Program VA’s pharmacy services division serves over 5.5 million veterans each year ♦ Launched February 2010 in four state region ♦ Provided medical waste and unused medication disposal

Slide 11: Key Markets: Government Contracts
800.772.5657 / www.sharpsinc.com Key Markets: Government Contracts Sharps Proprietary Medical Waste Management System Opportunity to expand to cover more people and to cover unused medications ♦ Rapid-deployment solution in the event of an emergency ♦ Increasingly recognized part of emergency prepar

Slide 12: Channels to Market
Channels to Market Increased Brand Awareness Retail Hospitality Assisted living Commercial / Industrial Pharmaceutical Manufacturers Government Managed Care Organizations Dentists Doctors Veterinarians Home Healthcare Pharmacies

Slide 13: Financial Highlights
800.772.5657 / www.sharpsinc.com Financial Highlights

Slide 14: Solid Business Model
Solid Business Model Recurring Revenue Early Market Penetration First Mover Advantage Unique Operating Leverage

Slide 15: Billings by Markets Segment
Billings by Markets Segment FY 2008 Billings $13.2 million

Slide 16: Full Fiscal Year Results
($ in millions) Full Fiscal Year Results Core Revenue $39.2 $19.4 $20.3 Gross Margin Operating Margin Net Income * Excludes special charge of $512 thousand and, for net income, an unusual tax benefit of $1.8 million. ** Excludes Q1 FY 2011 special charge of $570 thousand and Q4 FY 2011 unusual expen

Slide 17: Quarterly Performance
Quarterly Performance ($ in millions) Core Revenue Gross Margin Operating Margin Net Income $4.3 $4.8 $4.2 * Excludes Q1 FY2011 special charge of $570 thousand ** Excludes Q4 FY 2011 unusual expenses of $398 thousand $4.6 $5.0 $4.5 $4.2 $5.2

Slide 18: Strong Balance Sheet
Strong Balance Sheet Cash and Cash Equivalents $18.3M Shareholder Equity Growth Q4 09 vs. Q4 11 170% Line of Credit $5.0M (As of and for the period ending June 30, 2011) No debt as of 6/30/11

Slide 19: Waste Conversion Process
Waste Conversion Process™ ü No landfills required ü Creates a useful raw material ü Safe - 99.999% sterilized, and completely safe to handle ü Environmentally responsible - reduces carbon footprint ü Facilitates corporate environmental initiatives ü Significant differentiator for the Company Patent-

Slide 20: Estimated $2.8 billion market opportunity
* Estimated $2.8 billion market opportunity « First mover advantage « Increased state and federal regulatory drivers * Vertically integrated full-service operations « Highly scalable business model with operating leverage « Proven experienced management team y y y y Y a ame = 800.772.5657 / www.shar

Slide 21: Supplemental Information
800.772.5657 / www.sharpsinc.com Supplemental Information

Slide 22: Definitions
800.772.5657 / www.sharpsinc.com Definitions • Sharps Recovery System™ (formerly Sharps Disposal by Mail System®) A cost-effective and comprehensive solution for the containment, transportation, treatment and tracking of medical waste and used healthcare materials such as hypodermic needles, lancets

Slide 23: Definitions
800.772.5657 / www.sharpsinc.com Definitions Sharps®MWMS™ - Sharps Medical Waste Management System™ A comprehensive solution which includes an array of services and products necessary to effectively collect, store, transport, treat, document and audit medical waste and dispensed unused medications g
Source: SEC EDGAR · 8-K filed Sep 7, 2011
More decks from Sharps Compliance Corp
Investor Presentation (January 2014)28 slides · Jan 10, 2014
Investor Presentation (January 2012)31 slides · Jan 24, 2012
Credit Suisse 13th Annual Global Services Conference (March 2011)20 slides · Mar 14, 2011
William Blair Emerging Growth Stock Conference 201021 slides · Oct 1, 2010
Investor Presentation (May 2009)22 slides · May 14, 2009
Investor Presentation (July 2007)21 slides · Jul 11, 2007